• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Consumer Cyclical·7731.T
Share

Nikon Corporation Stocks

¥ 1631Last Updated 13.11.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

¥ 3.15B

¥ 1631
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very poor margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

29.08.2025 12:23

'Kodak moment': Will nostalgia for film be enough to save Kodak?

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nikon Corporation, a prominent international enterprise established in Tokyo, Japan, in 1917, specializes in the production and distribution of optical instruments. The company maintains a significant global footprint, with operations extending across Japan, North America, Europe, China, Thailand, and other key international markets. Its business activities are organized into three primary segments: Imaging Products, Precision Equipment, and Healthcare. The Imaging Products segment is dedicated to the development, manufacturing, sales, and servicing of a wide range of photographic equipment, including digital SLR cameras, compact digital cameras, and interchangeable lenses. The Precision Equipment segment focuses on providing advanced lithography systems for both flat panel displays (FPD) and semiconductor fabrication. Within the Healthcare segment, Nikon offers essential tools such as biological microscopes, systems for observing cell cultures, and state-of-the-art ultra-wide field retinal imaging devices. Beyond these core divisions, Nikon's extensive product portfolio encompasses industrial microscopes, various measuring instruments like non-contact 3D metrology systems and X-ray/CT inspection systems, and surveying equipment. The company further supplies customized products, optical glass, encoders, and ophthalmic lenses. Additional offerings include photomask substrates, camera components, sport optics products, and molded optical glasses. Moreover, Nikon is actively involved in the development and support of computer software.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair val

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 7731.T is 1702 and suggests 6.12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.11.2026 03:32

SpaceX has successfully caught Starship with its capture tower for the first time. What does this mean for the stock?

14.11.2026 17:01

What's New in Small-Cap Stocks: The Forbes Ranking, Oklo's Plans for Meta, and Ceco's Record

14.11.2026 13:01

Is There Life After Huang? The Rise of Anthropic, and the AI Rally in the Clouds

14.11.2026 04:56

Key Starship tests did not go as planned. SpaceX shares fell

14.11.2026 04:35

The S&P 500 posted its best week in six months. Barclays expects growth for the first time since March

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026